Journal article
Meningococcal polysaccharide-protein conjugate vaccines.
- Abstract:
-
It is now 5 years since the UK became the first country to introduce the serogroup C meningococcal polysaccharide-protein conjugate vaccines (MenC) into its routine immunisation schedule. This article reviews the global use of MenC with particular reference to the range of immunisation strategies used internationally. To date, concerns that MenC may result in an increase in meningococcal disease due to non-C serogroups have not been realised. The vaccine has proved to be highly safe and effec...
Expand abstract
- Publication status:
- Published
Actions
Authors
Bibliographic Details
- Journal:
- Lancet. Infectious diseases
- Volume:
- 5
- Issue:
- 1
- Pages:
- 21-30
- Publication date:
- 2005-01-01
- DOI:
- EISSN:
-
1474-4457
- ISSN:
-
1473-3099
- Source identifiers:
-
119379
Item Description
- Language:
- English
- Keywords:
- Pubs id:
-
pubs:119379
- UUID:
-
uuid:b24cab75-c117-4060-9a27-8fde26e9093f
- Local pid:
- pubs:119379
- Deposit date:
- 2012-12-19
Terms of use
- Copyright date:
- 2005
If you are the owner of this record, you can report an update to it here: Report update to this record